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Original article
Differences in systolic blood pressure (BP) between right and 
left arms ≥10 mm Hg independently predict increased risk of 
cardiovascular events,1,2 subclavian stenosis,3 and cardiovas-
cular or all-cause mortality.2 Measuring BP in both arms is 
a simple intervention that identifies the higher reading arm, 
which should be used for future hypertension management, 
and may identify patients needing investigation, or intensi-
fication of cardiovascular risk management.4 Prevalence of 
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BACKGROUND
Interarm differences (IADs) ≥10 mm Hg in systolic blood pressure (BP) 
are associated with greater incidence of cardiovascular disease. The 
effect of ethnicity and the white coat effect (WCE) on significant systolic 
IADs (ssIADs) are not well understood.
METHODS
Differences in BP by ethnicity for different methods of BP measurement 
were examined in 770 people (300 White British, 241 South Asian, 229 
African-Caribbean). Repeated clinic measurements were obtained simul-
taneously in the right and left arm using 2 BPTru monitors and com-
parisons made between the first reading, mean of second and third and 
mean of second to sixth readings for patients with, and without known 
hypertension. All patients had ambulatory BP monitoring (ABPM). WCE 
was defined as systolic clinic BP ≥10 mm Hg higher than daytime ABPM.
RESULTS
No significant differences were seen in the prevalence of ssIAD between 
ethnicities whichever combinations of BP measurement were used and 
regardless of hypertensive status. ssIADs fell between the 1st measure-
ment (161, 22%), 2nd/3rd (113, 16%), and 2nd–6th (78, 11%) (1st vs. 2nd/3rd 
and 2nd–6th, P < 0.001). Hypertensives with a WCE were more likely to 
have ssIADs on 1st, (odds ratio [OR] 1.73 (95% confidence interval 1.04–
2.86); 2nd/3rd, (OR 3.05 (1.68–5.53); and 2nd–6th measurements, (OR 2.58 
(1.22–5.44). Nonhypertensive participants with a WCE were more likely 
to have a ssIAD on their first measurement (OR 3.82 (1.77 to −8.25) only.
CONCLUSIONS
ssIAD prevalence does not vary with ethnicity regardless of hyper-
tensive status but is affected by the number of readings, suggesting 
the influence of WCE. Multiple readings should be used to confirm 
ssIADs.
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patients with a significant systolic interarm difference (ssIAD) 
varies according to population. A  U.S.  systematic review, 
found the prevalence of ssIADs was 7.5% in primary care, 9% 
for hospital outpatients, and 12.1% for hospital inpatients.5 
A recent study using Framingham data found the prevalence 
of ssIADs in a community sample, free from cardiovascular 
disease at baseline, was 9.4%. A UK systematic review con-
sidered prevalence of ssIADs in relation to clinical predic-
tors and found 11.2% in hypertensives, 7.4% in people with 
diabetes and 3.6% in the general population.6 Characteristics 
associated with ssIADs are age,1,7–9 diabetes,1 higher systolic 
BP,1,6,8 and increased body mass index (BMI).1
Some ethnic groups are at higher cardiovascular risk.10–13 
South Asians and African-Caribbeans have a higher inci-
dence of diabetes than White Europeans,14 and African-
Caribbeans have a greater prevalence of hypertension and 
stroke.15,16 Ethnicity may also affect the prevalence of ssIADs. 
Countries in the Far East appear to have a lower prevalence 
of patients with ssIADs than Western populations.6,8,17,18 
To our knowledge, there has only been one study so far to 
look at the effect of ethnicity on the prevalence of ssIADs.7 It 
found a higher prevalence of ssIADs ≥15 mm Hg in African 
American and White Americans compared to Hispanic or 
Chinese Americans.
Method of measurement affects the likelihood of finding a 
ssIAD; single or sequential BP measurement techniques may 
overestimate the prevalence.6,19,20
This study, using simultaneous measurements, aimed 
to evaluate whether prevalence of ssIADs ≥10  mm Hg 
varied according to South Asian, African-Caribbean, or 
White British ethnicity, hypertensive status or other par-
ticipant characteristic and additionally to investigate any 
association of prevalence with the number of readings, or 
the presence of a white coat effect (WCE) or white coat 
hypertension (WCH).
METHODS
Blood pressure monitoring in different ethnic groups 
(BP-ETH), was a primary care based observational study 
conducted between June 2010 and December 2012. The 
detailed methods have been published previously21 and are 
outlined below.
Population
Participants were aged 40–74 years, purposefully recruited 
from 3 ethnic groups: White British (WB), South Asian (SA), 
and African-Caribbean (AC). Ethnicity was self-defined 
using standard UK criteria.22 Respondents attended 3 
research clinics at their own practice. Twenty-eight practices 
were recruited from the Primary-Care-Research-Network, 
Central England, United Kingdom, chosen to represent the 
required range of ethnicities. Around 40 participants were 
recruited from each practice, both with (HT) and without 
hypertension (NHT), as defined by a clinical code in the 
patient’s record. People unable to consent, belonging to a 
different ethnic group or whose general practitioner felt they 
were unable to take part were excluded.
Procedure
Following at least 5 minutes rest, sitting BP measurements 
were taken by a research nurse using 2 BPTru monitors 
(BpTru Medical Devices BPM-200), set to take 6 readings at 
1-minute intervals and used simultaneously on both arms.23 
Monitors were calibrated independently to the same stand-
ard at the start of the study and the BPTru device performs 
an autocalibration upon activation to maintain accuracy. 
The research nurse remained in the room with the patient 
while the readings were being taken. One BPTru monitor 
was used consistently for the right arm and the second used 
for the left. This is considered to be the most accurate way of 
establishing an IAD.6,19,20
Participants were fitted with an ambulatory moni-
tor (Spacelabs 90217-1Q)24 on either the first or second 
clinic visit.
Ambulatory BP monitoring (ABPM) readings were 
recorded at half hourly intervals during the day and hourly 
overnight for a total of 24 hours. Participants’ nondominant 
arm was used unless systolic BP was ≥20 mm Hg between 
the right and left arm on the first reading, which included 
32 patients. In the case of these patients, the arm with the 
higher reading was used.
Analysis
ssIAD for the first measurement was defined as an abso-
lute difference ≥10 mm Hg between the right and left arm.3 
SSIADs were further defined using absolute ssIADs of the 1st 
reading alone, mean of the 2nd/3rd and mean of the 2nd to 6th 
readings.
There is no accepted definition of the WCE or WCH 
therefore different analyses were undertaken based on the 
literature25,26 using the following systolic BP definitions:
1. White coat effect (1st BP measurement):
 a.  (1st clinic measurement–mean daytime ABPM) 
≥10 mm Hg
2. White coat effect (mean of 2nd/3rd BP measurements)
 b.  (Mean of 2nd/3rd clinic measurement–mean daytime 
ABPM) ≥10 mm Hg
3. White coat effect (2nd–6th BP measurement)
 c.  (Mean of 2nd–6th clinic measurement–mean daytime 
ABPM) ≥10 mm Hg
Trends between the ethnic groups for prevalence of ssI-
ADs were tested using the Extended Mantel-Haenszel chi-
squared test for linear trend.27
Univariable analyses were conducted between ssIADs and 
baseline characteristics stratified by diagnosed hypertension 
(HT) and not known to be hypertensive (NHT) patients. 
Chi-squared test was used when comparing binary/categori-
cal variables. The 2 sample t-test was used when comparing 
the mean difference between 2 groups. Nonparametric tests 
were used for skewed variables such as BMI.27
A multivariate logistic regression model was also used 
where we adjusted for the following variables: ethnicity, 
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diabetes, age, gender, CHD, log(BMI), mean BP, medication, 
smoking, and deprivation score.
Differences in the proportion of patients with an absolute 
ssIAD, dependent on the number of measurements, were 
investigated using a Cochran Q test.27 All BP comparisons 
were for measurements in the same arm.
The same analysis was conducted checking for any differ-
ences in the prevalence of the WCE across different combi-
nations of measurements. Post-hoc analyses were conducted 
using the McNemar test.27 Association between ssIADs and 
the corresponding WCE was examined by the use of logistic 
regression models adjusted for baseline characteristics.
Sensitivity analyses were carried out to check the effect on 
WCE when using differences between clinic systolic BP and 
systolic ABPM of 5 and 15 mm Hg.
Ethics and research governance approval
Ethical approval for the BP-ETH study was gained from 
the Black Country Research Ethics Committee, West 
Midlands, United Kingdom (Ref 09/H1202//114).
RESULTS
Baseline demographic data
Seven hundred and seventy people participated in 
BP-ETH of whom 300 were WB, 229 were AC, and 241 were 
SA (Supplementary Table  1a—Appendix). There were no 
significant differences in baseline characteristics between 
WB, AC, and SA groups, or between HT and NHT partici-
pants, although more HT participants (481) were recruited 
than NHT (289).
Prevalence of IADs by ethnicity and hypertensive status
BP measurements in the right and left arms were avail-
able for 750 of the 770 participants who were grouped into 
HT and NHT and then subdivided into participants with a 
ssIAD or not. There was no systematic difference in the sys-
tolic BP of the right arm vs. that of the left (Supplementary 
Table  2a—Appendix); therefore, the following ssIADs are 
expressed as an absolute difference.
The overall prevalence of ssIADs for HT participants was 
61/469 (13.0%) and 26/281 (9.3%) for NHT participants 
(Table 1). Overall prevalence of ssIADs in the HT was group 
was higher but this difference was not found to be significant 
(Table 1). Association between ssIAD and ethnic group was 
not significant for the HT or NHT group (Table  1). There 
were no significant differences in the prevalence of ssIAD 
by ethnicity in the HT and NHT groups whichever combi-
nation of measurements was used (1st, mean of 2nd/3rd, or 
mean of 2nd–6th). Therefore only the sIAD using the mean 
of the 2nd–6th measurement is presented here as prevalence 
dropped the more measurements were used and this mean 
represented the nadir. A  multivariate logistic regression 
model was used where we adjusted for diabetes, age, gender, 
CHD, log(BMI), deprivation score, and mean BP. Ethnicity 
remained nonsignificant in both HT and NHT patients 
(Table 3).
Characteristics of participants with and without an IAD
Table  2 shows characteristics of participants with and 
without a ssIAD by hypertensive status. As the prevalence 
of ssIADs was not significantly associated with ethnic-
ity, the 3 ethnic groups are combined for analysis of the 
remaining characteristics. Significantly higher mean BP 
was associated with a ssIAD for both HT (140.1  mm Hg 
[ssIAD] vs. 131.6 mm Hg [no ssIAD], P < 0.001) and NHT 
groups (132.0 mm Hg [ssIAD] vs. 124.7 mm Hg [no ssIAD], 
P = 0.031) (Table 2). The multivariate analysis also showed a 
significantly higher BP was associated with a ssIAD in both 
the HT and NHT groups (Table 3). Significantly higher day-
time ABPM was associated with a ssIAD in the HT but not 
the NHT group.
As BMI was a skewed variable, this is reported as a 
median value with an interquartile range using the nonpar-
ametric test Wilcoxon rank sum for the P value (Table 2). 
Participants with a ssIAD had a significantly higher BMI in 
the HT group (31.0 kg/m2 vs. 28.7 kg/m2, P = 0.025); how-
ever, this significance disappeared in the multivariate analy-
sis (Table 3). Similarly in the NHT group, where ssIAD was 
actually associated with a lower BMI (27.3 kg/m2 vs. 29.4 kg/
m2, P = 0.025) (Table 2), the BMI no longer remained sig-
nificant in the multivariate analysis (Table  3). Multivariate 
analysis showed that NHT participants with a ssIAD were 
significantly more likely to smoke, which may have affected 
the univariate analysis of BMI.
Difference in age between HT participants with a ssIAD 
and HT participants without a ssIAD was of borderline sig-
nificance (58.4 vs. 60.8, P = 0.053). This effect was not seen 
Table 1. Incidence of sIADs by hypertensive status and ethnic group
Prevalence of systolic interarm BP absolute difference for second to sixth measurement
Known hypertensive (HT) Not known to be hypertensive (NHT)
≥10 mm Hg (n = 61) <10 mm Hg (n = 408) P value ≥10 mm Hg (n = 26) <10 mm Hg (n = 255) P value
Overall, No. (%) 61 (13.0) 408 (87.0) 26 (9.3) 255 (90.7)
 WB, No. (%) 17 (40) 162 (28) 0.188 10 (38) 101 (40) 0.892
 SA, No. (%) 20 (29) 120 (33) 10 (38) 87 (34)
 AC, No. (%) 24 (31) 126 (39) 6 (23) 67 (26)
Abbreviations: AC, African-Caribbean; BP, blood pressure; SA, South Asian; sIAD, Systolic Interarm Differences; WB, White British.
4 American Journal of Hypertension
Schwartz et al.
in the NHT group and the effect was no longer significant 
when other variables were accounted for in the multivari-
ate analysis (Table 3). There were no other significant dif-
ferences between participants with and without ssIAD 
(Table 2).
Changes in interarm BP differences between the 1st reading, 
2nd and 3rd reading, and 2–6th reading
Out of 469 HT participants, 449 had all 6 BP readings 
available on both arms. The number of participants with a 
Table 3. Multivariable analysis showing the likelihood of a ssIAD for the HT and NHT groups
Variables Known hypertensive (HT) (n = 437) (OR) Not known to be hypertensive (NHT) (n = 262) (OR)
WBa 1 1
SA 1.9 (0.851–4.333) 1.2 (0.386–3.916)
AC 1.7 (0.777–3.919) 0.8 (0.226–2.963)
Diabetes 1.2 (0.597–2.483) 0.5 (0.0524–5.495)
Age 1.0 (0.940–1.011) 1.0 (0.936–1.058)
Sex (Men) 0.8 (0.446–1.527) 0.8 (0.324–2.128)
CHD 0.6 (0.177–2.169) 1.4 (0.0663–29.91)
BMIb (log transformed) 2.6 (0.580–11.46) 0.2 (0.0141–3.170)
Mean blood pressure 1.03*** (1.010–1.043) 1.03** (1.006–1.064)
On medication 0.8 (0.158–4.160) 0.8 (0.0410–15.17)
Smoker 0.9 (0.333–2.184) 5.4*** (1.887–15.21)
IMDc 1.0 (0.988–1.004) 1.0 (1.000–1.003)
Abbreviations: AC, African-Caribbean; CHD, coronary heart disease; OR, odds ratio; SA, South Asian; ssIAD, significant systolic interarm 
differences; WB, White British.
aReference category ***P < 0.01 **P < 0.05.
bBody mass index.
cIndex of multiple deprivation 2007.
Table 2. Showing demographic and health differences between those patients with an interarm BP difference and those without for the HT 
and NHT groups
Systolic interarm BP absolute difference for second to sixth measurement
Known hypertensive (HT) Not known to be hypertensive (NHT)
Variable ≥10 mm Hg (n = 61)a <10 mm Hg (n = 408)a P value ≥10 mm Hg (n = 26)a <10 mm Hg (n = 255)a P value
Age (years) 58.4 (8.9) 60.8 (8.8) 0.053 54.8 (9.1) 53.9 (9.4) 0.669
Men 26 (43%) 208 (51%) 0.223 11 (42%) 121 (47%) 0.617
Mean blood Pressurea (n = 52) (n = 386) <0.001 (n = 24) (n = 239) 0.02
SD 143.7 (19.6) 134.1 (17.6) 135.3 (15.8) 126.4 (17.2)
BMIb (kg/m2) 31.0 (26.7–34.3) 28.7 (25.5–32.1) 0.0254 27.3 (24.9–30.6) 29.4 (26.5–33.5) 0.025
Coronary heart disease 5 (8%) 53 (13%) 0.403 2 (8%) 9 (4%) 0.270
Diabetes 16 (27%) 94 (23%) 0.536 1 (4%) 16 (6%) 0.519
Mean deprivation scorec (n = 60) (n = 384) 0.572 (n = 21) (n = 236) 0.79
SD 44.1 (17.55) 42.8 (17.58) 41.3 (19.18) 42.3 (17.11)
Mean daytime ABPMa (n = 47) (n = 341) 0.003 (n = 22) (n = 209) 0.19
SD 139.5 (15.8) 132.8 (14.3) 133.2 (15.0) 129.3 (12.8)
Taking antihypertensive 
medication (Y)
58 (95%) 396 (97%) 0.308 1 (4%) 15 (6%) 1.00
Smoking (Y) 6 (10%) 60 (15%) 0.207 10 (38%) 28 (11%) 0.001
Abbreviations: ABPM, ambulatory blood pressure monitoring BP, blood pressure.
aNumber of participants unless otherwise stated.
bmm Hg.
cBMI, body mass index, reported as a median value with (interquartile range).
dIndex of multiple deprivation 2007.
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ssIAD fell as more pairs of readings were included in the cal-
culation of mean BP (Supplementary Table 3a—Appendix): 
101 (22%) for the 1st measurement, 69 (15%) for the mean of 
the 2nd/3rd measurements, and 54 (12%) for the mean of the 
2nd–6th measurements. Post-hoc analysis revealed a signifi-
cant difference (P < 0.001) between the number of partici-
pants with a ssIAD on the 1st pair of readings vs. the number 
with a ssIAD on the mean of the 2nd/3rd and the 2nd–6th pairs 
of readings, with a smaller nonsignificant difference between 
the latter 2 measurement methods (Supplementary Table 
3a—Appendix). NHT (271/281) patients showed a similar 
pattern (Supplementary Table 3a—Appendix).
This effect was mirrored by the decline in the prevalence 
of a WCE; numbers of HT participants with a WCE on the 1st 
measurement was 128 (35%), 89 (25%) for the mean of the 
2nd/3rd, and 66 (18%) for 2nd–6th BP readings (1st vs. 2nd/3rd 
P < 0.001; 1st vs. 2nd–6th reading P < 0.001) (Supplementary 
Table 4a—Appendix). This decline was also seen in the NHT 
participants (Supplementary Table 4a—Appendix).
Association of the WCE and interarm BP difference
The relationship between the WCE and ssIAD was inves-
tigated using a logistic regression model and adjusted for 
baseline characteristics. Resulting odds ratios show that in 
the HT group there was a significant association between the 
WCE and ssIAD for the 1st measurement, 2nd/3rd, and 2nd–6th 
measurement (Table 4).
In the NHT group, the odds ratio was significant for the 
association between WCH and ssIAD for the first reading 
(4.06, 95% confidence interval, 1.83, 9.00) (Table 4) but no 
significant differences were found in the association of WCH 
and ssIAD between the mean of the 2nd/3rd and the 2nd–6th 
readings (Table 4).
Sensitivity analyses using definitions of a 5 mm Hg and 
15  mm Hg difference between clinic systolic BP and the 
systolic mean daytime ABPM showed a similar pattern of 
results (Supplementary Tables 5a and 6a—Appendix).
DISCUSSION
Summary
In this community-based study, ethnicity had no signifi-
cant impact on the prevalence of ssIAD. The HT group had 
a greater prevalence of ssIADs overall but the difference 
between the HT and the NHT groups was not significant. 
However, the prevalence of ssIADs significantly increased 
with increasing BP regardless of hypertensive status. NHT 
Participants with a ssIAD were more likely to be a smoker, 
but there did not appear to be the same association for BMI 
and age. There was no systematic difference in systolic BP 
between the right and the left arm, which was in keeping 
with the results of a recent meta-analysis.28
Calculating ssIAD with increasing numbers of repeated 
measurements significantly reduced the prevalence of a 
ssIAD and this appeared to be associated with the WCE, 
especially for HT participants. For NHT participants, the 
association between a ssIAD and WCH was present on the 
first measurement but not thereafter.
Strengths and Limitations
The main strength of this study was that it was large, com-
munity-based, and recruited approximately equal numbers 
of patients from each of 3 ethnic groups. It included patients 
with a diagnosis of hypertension, those with no known 
diagnosis and did not exclude patients with comorbidities. 
Measurements were taken in a Primary Care setting, which 
is where most office BP is taken and provides the most gen-
eralizable comparison of the WCE.29 The study used 6 BP 
measurements, allowing for analysis of ssIADs over several 
consecutive readings, and measurements were taken simul-
taneously with a validated monitor which is widely acknowl-
edged as the most accurate way to measure IAD.19,30,31 There 
is a theoretical bias arising from the use of different moni-
tors on each arm, which could not be helped as the BPTru 
monitor takes readings automatically at 1-minute intervals 
precluding switching of monitors between arms. However, 
the monitors were all calibrated prior to the start of the study 
and autocalibrate each time when activated therefore reduc-
ing the likelihood of monitors on different arms being in a 
different state of calibration.23 The number of patients with 
ssIADs was relatively small which affected power to assess 
associations and differences between groups. Only systolic 
BP was assessed therefore any associated or independent 
effects on IAD between diastolic BP are unknown.
The current study did not include Far Eastern ethnicities 
such as Chinese, who may have significantly lower incidence 
of ssIADs than Western groups.6 Despite the range of ethnic-
ities, there was only 1 area of the UK studied, which does not 
take into account potential effects different environments 
may have.
The population here came from more deprived areas in 
comparison with the rest of the UK. While we do not know 
what association deprivation would have with the prevalence 
Table 4. ORs for ssIADs when the WCE is present in HT and NHT groups
ORs for ssIAD when WCE is present in HT group ORs for ssIAD when WCE is present in NHT group
First pair of readings 2.12 (95% CI: 1.24–3.62; P = 0.006, n = 370) 4.06 (95% CI: 1.83–9.00; P = 0.001, n = 220)
Mean of the 2nd and 3rd pair of readings 3.69 (95% CI: 1.96–6.93; P < 0.001, n = 373) 1.07 (95% CI: 0.41–2.79; P = 0.888, n = 226)
Mean of the 2nd–6th pair of readings 3.48 (95% CI: 1.56, 7.71; P = 0.002, n = 364) 1.68 (95% CI: 0.451–6.32; P = 0.436; n = 219)
Logistic regression model was used and adjusted for gender, ethnicity, logarithm of BMI, age, CHD, daytime ABPM, diabetes, smoking, 
medication, and IMD. Abbreviations: CI, confidence interval; HT, known hypertensive; IMD, index of multiple deprivation; NHT, not known to be 
hypertensive; OR, odds ratio; ssIAD, significant systolic interarm differences; WCE, white coat effect.
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of ssIADs, hypertension is more prevalent in deprived set-
tings so a concomitant trend to increased prevalence of ssI-
ADs with deprivation might be predicted.32
In this study, the definition of a clinically significant sys-
tolic IAD was defined as ≥10  mm Hg. Current European 
hypertension guidelines suggest a ssIAD >10  mm Hg 
between arms carries an increase in cardiovascular risk33 
and although the UK guidelines suggest a difference in sys-
tolic BP ≥20 mm Hg is indicative of vascular disease, they 
only specify a ssIAD <10  mm Hg as normal.4 Although a 
ssIAD ≥10 mm Hg may show less specificity for peripheral 
artery disease than that of 15 mm Hg, it is more sensitive34 
and, in addition, it is in keeping with the definition used in 
many current studies.1,3,5,35 Using this definition meant that 
our work could be compared to the current literature more 
easily and was clinically relevant.
As there is no accepted definition of the WCE or WCH, 
a pragmatic definition for the study was developed using an 
arbitrary level of the clinic-ambulatory difference (≥10 mm 
Hg).4 Differences between clinic and ambulatory BP are 
potentially subject to bias, principally from variation in 
the clinic BP due to operator error, hypertensive status and 
activities, and environment of the patient.36 However, given 
the controlled nature of the research measurements, such 
errors would be expected to be minimized in this study.
Comparison with existing literature
The prevalence of ssIADs in the HT and NHT groups 
was 13.0% and 9.3%, respectively. In the NHT group, this 
appeared to be high for a general population.6
A recent systematic review, analysing prevalence of ssI-
ADs from 16 studies, found a prevalence of 3.6%. However, 
the population group included 2 studies of Far Eastern origin 
which had a much lower prevalence than studies of Western 
origin and therefore reduced the pooled prevalence.6 There 
was a higher prevalence in a hypertensive population 
(11.2%) and when studies causing statistical heterogene-
ity were removed, the prevalence of ssIADs in a Western, 
hypertensive population was 13.3%, almost identical to the 
prevalence found here.6 Similar to the current study, the 
multiethnic study of atherosclerosis (MESA) also reported 
no significant differences in ssIADs between African 
American and White non-Hispanic groups.7 However, there 
was a significantly lower prevalence of ssIADs in Hispanic 
and Chinese Americans suggesting that Hispanic and Far 
Eastern ethnicities may be less predisposed to ssIADs than 
Western populations.
A higher BMI has been previously reported1,7,8 as being 
associated with a ssIAD and is likely to relate to patients 
with ssIADs having a higher cardiovascular risk.1 However, 
another study9 found that age was the only significant pre-
dictor for ssIADs. Neither age nor BMI was found to have 
a significant association here with a ssIAD in the HT or 
NHT group. However, BMI was higher in the HT group so 
this may have been compounded by the fact that the num-
ber of patients with a ssIAD was small. The NHT group 
had a significant association between smoking and ssIAD, 
which is in keeping with the link between ssIADs and a 
greater cardiovascular risk. However, the link between 
smoking and ssIADs is varied with some studies show-
ing some association7 but others showing no significance.1 
The number of participants in this study who smoked was 
very small and is likely to affect the significance of any 
associations here.
Results here are in agreement with that found in the 
Framingham Heart Study, a study in a Japanese population 
and a recent large meta-analysis of 16 IAD studies showing 
that those patients with a ≥10  mm Hg difference between 
arms had significantly higher systolic BP compared to those 
without.1,6,8 This is likely to be an effect of the absolute IAD 
increasing as absolute BP increases and may in part explain 
why patients with a ssIAD appear to be at higher risk of a 
cardiovascular event.1
Systolic BP decreased over the 6 clinic measurements, 
and the prevalence of ssIAD followed the same pattern. This 
pattern has been seen in other studies35,37,38 and a study by 
Martin et al. suggested that the effect may be associated with 
the WCE,30 although they used sequential measurements to 
estimate IAD which can overestimate its prevalence.19
A significant association was found here between WCH 
and ssIAD on the first reading for participants in the NHT 
group and between the WCE and ssIADs for all BP measure-
ments used in the HT patients.
For HT patients, the strongest association between 
the WCE and ssIAD was using the mean of 2nd/3rd read-
ings which may be explained by HT participants hav-
ing a stronger, more persistent WCE than those with no 
diagnosis. There is closer agreement between clinic and 
ambulatory BP when a patient’s BP is closer to normal lev-
els.33,36,38–40 This suggests that the increase in prevalence of 
ssIADs in response to higher BP levels may be linked to 
the WCE.
Implications for practice
There appears to be little difference in the prevalence 
of ssIADs between SA and AC cohorts compared to a WB 
population. However, those with higher mean clinic BP were 
more likely to have a ssIAD regardless of hypertensive status. 
European guidelines recommend simultaneous measure-
ment to exclude clinical ssIADs.33 A much greater effect was 
seen in terms of the number of measurements used; hence, 
health professionals should not rely on single BP measure-
ments to identify ssIADs.
This study and others19 have shown that the prevalence 
of a ssIAD continues to fall when greater numbers of pairs 
of readings are taken into account. Therefore, if a ssIAD 
is detected on the first measurement, we propose that BP 
should be taken simultaneously at least 3 times in both 
arms with the mean IAD calculated for the 2nd and 3rd 
readings in order to more accurately estimate a “true” 
IAD.
SUPPLEMENTARY MATERIAL
Supplementary data are available at American Journal of 
Hypertension online.
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